Description
Biguanide derivative that improves insulin sensitivity and decrease insulin resistance by inhibiting complex 1 of the mitochondrial respiratory chain and inducing AMPK-dependent signaling; inhibits peripheral glucose oxidation, has an associated effect of inducing lactic acidosis when not metabolized sufficiently, and exhibits anticancer activity via AMPK activation
Formal name: N-(2-phenylethyl)-imidodicarbonimidic diamide, monohydrochloride
Synonyms:
Molecular weight: 241.7
CAS: 834-28-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Activators|Kinases||Research Area|Cancer|Cell Signaling||Research Area|Cancer|Metabolism||Research Area|Cell Biology|Mitochondrial Biology||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Nutrient Sensing